The leaching out
of toxic elements from metallic bioimplants has serious repercussions,
including allergies, peripheral neuritis, cancer, and Alzheimer’s
disease, leading to revision or replacement surgeries. The development
of advanced structural materials with excellent biocompatibility and
superior corrosion resistance in the physiological environment holds
great significance. High entropy alloys (HEAs) with a huge compositional
design space and outstanding mechanical and functional properties
can be promising for bioimplant applications. However, microstructural
heterogeneity arising from elemental segregation in these multiprinciple
alloy systems is the Achilles heel in the development of next-generation
HEAs. Here, we demonstrate a pathway to homogenize the microstructure
of a biocompatible dual-phase HEA, comprising refractory elements,
namely, MoNbTaTiZr, through severe surface deformation using stationary
friction processing (SFP). The strain and temperature field during
processing homogenized the elemental distribution, which was otherwise
unresponsive to conventional annealing treatments. Nearly 15 min of
the SFP treatment resulted in a significant elemental homogenization
across dendritic and interdendritic regions, similar to a week-long
annealing treatment at 1275 K. The SFP processed alloy showed a nearly
six times higher biocorrosion resistance compared to its as-cast counterpart.
X-ray photoelectron spectroscopy was used to investigate the nature
of the oxide layer formed on the specimens. Superior corrosion behavior
of the processed alloy was attributed to the formation of a stable
passive layer with zirconium oxide as the primary constituent and
higher hydrophobicity. Biocompatibility studies performed using the
human mesenchymal stem cell line, showed higher viability for the
processed HEA compared to its as-cast counterpart as well as conventional
metallic biomaterials including stainless steel (SS316L) and titanium
alloy (Ti6Al4V).